Acyclovir

Product NDC: 50090-0645
11-digit product format: 500900645
Labeler code: 50090
Product ID: 50090-0645_80c6d18c-2b7d-475d-92ed-0696f19a7bd3
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Acyclovir
Dosage form: TABLET
Route: ORAL
Labeler: A-S Medication Solutions
Application: ANDA075382
Marketing category: ANDA
Marketing start: 2009-10-22
Marketing end: 0000-00-00
Substance: ACYCLOVIR
Active strength: 400 mg/1
Pharmacologic classes: DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-0645-0	EA - Each	50090-0645	2c16f95c-b8ca-4c9f-b3cd-3a942a7147bb	1	2018-10-11
50090-0645-1	EA - Each	50090-0645	081c51bc-3789-40ad-8e26-946be673471a	1	2018-10-11

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X4HES1O11F	ACYCLOVIR	59277-89-3	ACYCLOVIR

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-0645-0	50090064500	90 TABLET in 1 BOTTLE (50090-0645-0)	90 tablet	2014-11-28	0000-00-00	No	No	Current
50090-0645-1	50090064501	21 TABLET in 1 BOTTLE (50090-0645-1)	21 tablet	2016-11-28	0000-00-00	No	No	Current